ZYRTEC
CETIRIZINE HYDROCHLORIDE
Approval overview ZYRTEC is listed in Drugs@FDA under application 020346 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CETIRIZINE HYDROCHLORIDE Form and strength SOLUTION;ORAL - 5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor J AND J CONSUMER INC Submission history Latest submission status date: 2004-03-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZYRTEC is listed in Drugs@FDA under application 020346 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CETIRIZINE HYDROCHLORIDE Form and strength SOLUTION;ORAL - 5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor J AND J CONSUMER INC Submission history Latest submission status date: 2004-03-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.